- Home
- SISI vs TTNP Comparison
SISI vs TTNP Comparison
Compare SISI & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- TTNP
- Stock Information
- Founded
- SISI 1997
- TTNP 1991
- Country
- SISI China
- TTNP United States
- Employees
- SISI N/A
- TTNP N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SISI Health Care
- TTNP Health Care
- Exchange
- SISI Nasdaq
- TTNP Nasdaq
- Market Cap
- SISI 6.5M
- TTNP 5.4M
- IPO Year
- SISI 2016
- TTNP 1996
- Fundamental
- Price
- SISI $5.33
- TTNP $4.93
- Analyst Decision
- SISI
- TTNP
- Analyst Count
- SISI 0
- TTNP 0
- Target Price
- SISI N/A
- TTNP N/A
- AVG Volume (30 Days)
- SISI 279.7K
- TTNP 48.5K
- Earning Date
- SISI 09-29-2025
- TTNP 08-18-2025
- Dividend Yield
- SISI N/A
- TTNP N/A
- EPS Growth
- SISI N/A
- TTNP N/A
- EPS
- SISI N/A
- TTNP N/A
- Revenue
- SISI $9,601,324.00
- TTNP N/A
- Revenue This Year
- SISI N/A
- TTNP N/A
- Revenue Next Year
- SISI N/A
- TTNP N/A
- P/E Ratio
- SISI N/A
- TTNP N/A
- Revenue Growth
- SISI 1133.26
- TTNP N/A
- 52 Week Low
- SISI $4.71
- TTNP $3.03
- 52 Week High
- SISI $852.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SISI 30.48
- TTNP 63.76
- Support Level
- SISI $6.10
- TTNP $3.88
- Resistance Level
- SISI $7.15
- TTNP $4.00
- Average True Range (ATR)
- SISI 1.21
- TTNP 0.37
- MACD
- SISI 0.06
- TTNP 0.08
- Stochastic Oscillator
- SISI 0.34
- TTNP 78.85
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.